Correlation Between Bio Techne and Sarepta Therapeutics
Can any of the company-specific risk be diversified away by investing in both Bio Techne and Sarepta Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bio Techne and Sarepta Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bio Techne and Sarepta Therapeutics, you can compare the effects of market volatilities on Bio Techne and Sarepta Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bio Techne with a short position of Sarepta Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bio Techne and Sarepta Therapeutics.
Diversification Opportunities for Bio Techne and Sarepta Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Bio and Sarepta is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Bio Techne and Sarepta Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sarepta Therapeutics and Bio Techne is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bio Techne are associated (or correlated) with Sarepta Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sarepta Therapeutics has no effect on the direction of Bio Techne i.e., Bio Techne and Sarepta Therapeutics go up and down completely randomly.
Pair Corralation between Bio Techne and Sarepta Therapeutics
If you would invest 0.00 in Sarepta Therapeutics on December 31, 2024 and sell it today you would earn a total of 0.00 from holding Sarepta Therapeutics or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 1.67% |
Values | Daily Returns |
Bio Techne vs. Sarepta Therapeutics
Performance |
Timeline |
Bio Techne |
Sarepta Therapeutics |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Bio Techne and Sarepta Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Bio Techne and Sarepta Therapeutics
The main advantage of trading using opposite Bio Techne and Sarepta Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bio Techne position performs unexpectedly, Sarepta Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sarepta Therapeutics will offset losses from the drop in Sarepta Therapeutics' long position.Bio Techne vs. Seagate Technology Holdings | Bio Techne vs. Raytheon Technologies | Bio Techne vs. GX AI TECH | Bio Techne vs. Paycom Software |
Sarepta Therapeutics vs. American Airlines Group | Sarepta Therapeutics vs. Patria Investments Limited | Sarepta Therapeutics vs. MAHLE Metal Leve | Sarepta Therapeutics vs. Deutsche Bank Aktiengesellschaft |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |